Serum pharmacokinetics in patients treated with transarterial chemoembolization (TACE) using two types of epirubicin-loaded microspheres

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 1769-1774

  Sottani, Cristina ^a   Poggi, Guido ^a   Quaretti, Pietro ^b   Regazzi, Mario ^b   Montagna, Benedetta ^a   Quaquarini, Erica ^a   Imbriani, Marcello ^a,c   Leoni, Emanuela ^a   Di Cesare, Pamela ^a   Riccardi, Alberto ^a   Bernardo, Giovanni ^a   Minoia, Claudio ^a  

^a IRCCS   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Epirubicin loaded microspheres; Hepatocellular carcinoma; LC ESI MS MS; Pharmacokinetic study; Transarterial chemo embolization (TACE)

Indexed keywords

EPIRUBICIN; MICROSPHERE;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TRANSARTERIAL CHEMOEMBOLIZATION;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPIRUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; QUALITY CONTROL;

EID: 84861487249     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Llovet JM, Burroughs A and Bruix J : Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003. (Pubitemid 37518510)
2. Llovet JM and Bruix J: Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48(Suppl 1): 20- 37, 2008.
3. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P and Lencioni R: Prospective randomized study of doxorubicin-eluting- bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33: 41-52, 2010.
4. Bruix J and Sherman M: Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022, 2011.
5. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J and Group BLC: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739, 2002. (Pubitemid 34607087)
6. Llovet JM and Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37: 429-442, 2003. (Pubitemid 36152543)
7. Hong K, Georgiades CS and Geschwind JF: Technology insight: Image-guided therapies for hepatocellular carcinoma: intra-arterial and ablative techniques. Nat Clin Pract Oncol 3: 315- 324, 2006.
8. Seki A, Hori S, Kobayashi K and Narumiya S: Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Intervent Radiol 34: 557-565, 2011.
9. Liapi E, Lee KH, Georgiades CC, Hong K and Geschwind JF: Drug-eluting particles for interventional pharmacology. Tech Vasc Interv Radiol 10: 261-269, 2007. (Pubitemid 351902189)
10. Malagari K: Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead. Expert Rev Anticancer Ther 8: 1643-1650, 2008.
11. Malagari K, Alexopoulou E, Chatzimichail K, Hall B, Koskinas J, Ryan S, Gallardo E, Kelekis A, Gouliamos A and Kelekis D: Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging 33: 512-519, 2008.
12. Jordan O, Denys A, De Baere T, Boulens N and Doelker E: Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC Bead and HepaSphere loaded with doxorubicin and irinotecan, J Vasc Interv Radiol 21: 1084-1090, 2010.
13. Lee KH, Liapi EA, Cornell C, Reb P, Buijs M, Vossen JA, Ventura VP and Geschwind JF: Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol 33: 576-582, 2010.
14. Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS and Geschwind JF: New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12: 2563-2567, 2006.
15. Bilbao JI, De Luis E, García de Jalón JA, De Martino A, Lozano MD, De la Cuesta AM and Sangro B: Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation. J Vasc Interv Radiol 19: 1625-1638, 2008.
16. Malagari K, Chatzimichael K, Alexopoulou E, Kelekis A, Hall B, Dourakis S, Delis S, Gouliamos A and Kelekis D: Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol 31: 269-280, 2008.
17. Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T, Moschouris H, Emmanouil E, Rizos S and Kelekis D: Prospective randomized comparison of chemo-embolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33: 541-551, 2010.
18. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, Ayuso C, Castells L, Montañá X, Llovet JM and Bruix J: Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46: 474-481, 2007. (Pubitemid 46201723)
19. Poon RT, Tso WK, Pang RW, Ng KK, Woo R, Tai KS and Fan ST: A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5: 1100-1108, 2007.
20. Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL, Leppard SW, Wolfenden LC, Palmer RR and Stratford PW: DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17: 335- 342, 2006.
21. Lewis AL, Gonzalez MV, Leppard SW, Brown JE, Stratford PW, Phillips GJ and Lloyd AW: Doxorubicin eluting beads-1: Effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med 18: 1691-1699, 2007. (Pubitemid 47224923)
22. Grosso M, Vignali C, Quaretti P, Nicolini A, Melchiorre F, Gallarato G, Bargellini I, Petruzzi P, Massa Saluzzo C, Crespi S and Sarti I: Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Intervent Radiol 31: 1141-1149, 2008.
23. Sottani C, Leoni E, Porro B, Montagna B, Amatu A, Sottotetti F, Quaretti P, Poggi G and Minoia C: Validation of an LCMS/ MS method for the determination of epirubicin in human serum of patients undergoing drug eluting microspheretransarterial chemoembolization (DEM-TACE). J Chromatogr B 877: 3543-3548, 2009.
24. Pernkopf I, Tesch G, Dempe K, Kletzl H, Schüller J and Czejka M: Binding of epirubicin to human plasma protein and erythrocytes: interaction with the cytoprotective amifostine. Pharmazie 51: 897-901, 1996. Article in German. (Pubitemid 26412713)
25. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G and Gandini G: Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma. Eur Radiol 16: 661-669, 2006. (Pubitemid 44149378)
26. Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE and Allgaier HP: Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterology 11: 6104-6109, 2005. (Pubitemid 43085049)
27. Dobbs NA, Twelves CJ, Rizzi P, Warwick JD, Metivier EM, Williams R and Johnson PJ: Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity. Cancer Chemother Pharmacol 34: 405-410, 1994. (Pubitemid 24261280)